These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23566410)

  • 1. Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
    Scantlebury JB; Luo J; Thorstad WL; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Aug; 44(8):1672-80. PubMed ID: 23566410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.
    Lin RJ; Lubpairee T; Liu KY; Anderson DW; Durham S; Poh CF
    J Otolaryngol Head Neck Surg; 2013 Mar; 42(1):23. PubMed ID: 23672832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
    Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
    Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.
    Hafkamp HC; Mooren JJ; Claessen SM; Klingenberg B; Voogd AC; Bot FJ; Klussmann JP; Hopman AH; Manni JJ; Kremer B; Ramaekers FC; Speel EJ
    Mod Pathol; 2009 May; 22(5):686-98. PubMed ID: 19305381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.
    Lewis JS; Ali S; Luo J; Thorstad WL; Madabhushi A
    Am J Surg Pathol; 2014 Jan; 38(1):128-37. PubMed ID: 24145650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer.
    Hong AM; Dobbins TA; Lee CS; Jones D; Fei J; Clark JR; Armstrong BK; Harnett GB; Milross CG; Tran N; Peculis LD; Ng C; Milne AG; Loo C; Hughes LJ; Forstner DF; O'Brien CJ; Rose BR
    Int J Cancer; 2011 Apr; 128(7):1532-45. PubMed ID: 20503270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of basaloid differentiation in oropharyngeal cancer.
    Cooper T; Biron V; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Dec; 42(1):57. PubMed ID: 24350944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.
    Lewis JS; Chernock RD; Ma XJ; Flanagan JJ; Luo Y; Gao G; Wang X; El-Mofty SK
    Mod Pathol; 2012 Sep; 25(9):1212-20. PubMed ID: 22596101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers.
    Lewis JS; Scantlebury JB; Luo J; Thorstad WL
    Am J Surg Pathol; 2012 Jul; 36(7):1036-46. PubMed ID: 22743286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.
    Lu XJD; Liu KYP; Soares RC; Thomson T; Prisman E; Wu J; Poh CF
    J Oral Pathol Med; 2018 Nov; 47(10):945-953. PubMed ID: 30191616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection.
    Cho YA; Chung JM; Ryu H; Kim EK; Cho BC; Yoon SO
    Cancer Res Treat; 2019 Jul; 51(3):1052-1063. PubMed ID: 30360033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
    Barasch S; Mohindra P; Hennrick K; Hartig GK; Harari PM; Yang DT
    Am J Surg Pathol; 2016 Sep; 40(9):1261-9. PubMed ID: 27186851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.